Published in BMJ Open on September 07, 2015
Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.78
Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset. Inflamm Bowel Dis (2017) 0.75
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut (2010) 6.34
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med (2011) 2.40
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology (2005) 2.05
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 1.81
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int (2005) 1.68
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum (2005) 1.58
Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflamm Bowel Dis (2010) 1.49
Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol (2011) 1.39
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. J Crohns Colitis (2010) 1.32
Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol (2007) 1.30
Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population. Clin Gastroenterol Hepatol (2012) 1.23
Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol (2011) 1.20
Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf (2005) 1.10
Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci (2012) 1.10
Publicly reported quality-of-care measures influenced Wisconsin physician groups to improve performance. Health Aff (Millwood) (2013) 1.08
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. Inflamm Bowel Dis (2011) 1.01
Infectious and malignant complications of TNF inhibitor therapy in IBD. Am J Gastroenterol (2013) 0.99
Moving towards disease modification in inflammatory bowel disease therapy. Curr Opin Gastroenterol (2013) 0.98
Mucosal healing and anti TNFs in IBD. Curr Drug Targets (2010) 0.98
Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf (2009) 0.97
Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol (2002) 0.97
Do cardiology quality measures actually improve patient outcomes? J Am Heart Assoc (2014) 0.95
Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am (2009) 0.95
Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2005) 0.94
Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Dig Dis (2013) 0.84
Health policy basics: physician quality reporting system. Ann Intern Med (2014) 0.83
A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases. Inflamm Bowel Dis (2014) 0.83
Defining a future for fee-for-service Medicare. Health Aff (Millwood) (2006) 0.82
Treatment of inflammatory bowel disease in the elderly: an update. Drugs Aging (2002) 0.81
Enrollment in prescription drug insurance: the interaction of numeracy and choice set size. Health Psychol (2013) 0.80
Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy. J Dig Dis (2014) 0.80
Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries. Arthritis Care Res (Hoboken) (2015) 0.78